Discover
LENZ
LENZ Therapeutics, Inc.
5.79
2 x 4.27
2 x 7.24
bid
ask
+
0.11
1.94%
2 @ 05:57 AM
5.80 +0.01 (0.17%)
| Ytd | -63.81% | |
| 1y | -81.30% |
5.57
day range
5.98
5.23
52 week range
50.40
| Open | 5.60 | Prev Close | 5.68 | Low | 5.57 | High | 5.98 | Mkt Cap | 181.54M |
| Vol | 523.99K | Avg Vol | 779.99K | EPS | -3.64 | P/E | N/A | Forward P/E | -13.35 |
| Beta | N/A | Short Ratio | 13.18 | Inst. Own | 99.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 7.61 | 200-d Avg | 18.66 | 1yr Est | 54.25 |
LENZ News
benzinga.com
LENZ Therapeutics Eye Drug Profile Supports Blockbuster Opportunity: Analyst
LENZ Therapeutics partners with Arrotex to commercialize VIZZ in Australia and New Zealand as analys
benzinga.com
LENZ Therapeutics And Arrotex Pharma Announce Exclusive License And Commercialization Agreement For
LENZ Therapeutics, Inc. (NASDAQ:LENZ) and Arrotex Pharmaceuticals Pty Ltd. ("Arrotex") today